<DOC>
	<DOCNO>NCT00195676</DOCNO>
	<brief_summary>The two objective study evaluate long-term efficacy safety adalimumab treatment participant moderate severe chronic plaque psoriasis evaluate effectiveness adalimumab retreatment participant therapeutic response adalimumab withdrawn adalimumab treatment .</brief_summary>
	<brief_title>Efficacy Safety Adalimumab Subjects With Moderate Severe Chronic Plaque Psoriasis</brief_title>
	<detailed_description>Study M03-658 continuation study participant moderate severe psoriasis participate prior psoriasis adalimumab study . Study M03-658 consist three sequential treatment period . The first period Period O , participant receive open-label treatment adalimumab ( 40 mg every week 40 mg every week ) minimum 104 week maximum 252 week . Period O period study May 2008 , subsequent period add via amendment protocol . At time , participant achieve satisfactory therapeutic response ( Physician 's Global Assessment [ PGA ] 0 , 1 , 2 [ clear , minimal , mild ] ) give opportunity discontinue study continue participate subsequent two period . The second period Period W , maximum 52 week , participant PGA 2 ( mild ) less withdrawn adalimumab treatment ( i.e. , participant receive treatment ) relapse psoriasis occur ( define PGA 3 [ moderate ] worse ) . The third period Period R , 16-week period participant retreat open-label adalimumab ( 80 mg initial dose follow 40 mg every week ) . Period O design evaluate first objective regard long-term efficacy safety adalimumab treatment , Period R design evaluate effectiveness adalimumab retreatment follow relapse . Specific subset study population identify population interest modify intent-to-treat population Period W Period R , describe outcome measure .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject age 18 old good health ( Investigator discretion ) recent stable medical history . Subjects met requirement previous adalimumab psoriasis study participation . Subject consider Investigator , reason , unsuitable candidate study . Female subject pregnant breastfeeding consider become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>